Abstract
The placenta is a complicated tissue that lies between maternal and fetal compartments. Although the architecture of the human and rodent placentas differ a little in their details, their overall structures and the molecular mechanisms of placental developments are thought to be very similar. In rats, fetal–placental exposure to maternally administered glucocorticoids decreases birth weight and placental weight. The mechanism underlying the placental growth inhibitory effects of glucocorticoids have not been elucidated. Moreover it is still not determined that how Akt and ERK1/2 proteins related proliferation and apoptosis mechanisms are influenced by dexamethasone-induced IUGR (Intrauterine Growth Restriction) placentas. The aim of this study was to investigate the expression levels and spatio-temporal immunolocalizations of Akt, p-Akt, ERK1/2 and p-ERK1/2 proteins in normal and dexamethasone treated placental development in pregnant Wistar rats. Pregnant rats were subcutaneously injected with 100 μg/kg dexamethasone 21-acetate in 0.1 ml 10% ethanol on day 10 and 12 of gestation. Afterwards injection was continued as 200 μg/kg until they were killed on day 12 (injection started on day 10), 14, 16, 18 and 20 (injections started on day 12) of pregnancy. Placental and embryonal tissues were collected for immunohistochemistry and Western blot analysis. We found that maternal dexamethasone treatment led to a decrease in ERK1/2 and Akt activation during rat placental development. The decrease in Akt and ERK1/2 activations may result with cell survival inhibition or apoptosis stimulation. Hence, dexamethasone induced placental and embryonal developmental abnormalities could be associated with reduction of Akt and ERK1/2 activation.
Similar content being viewed by others
References
Ain R, Canham LN, Soares MJ (2005) Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway. J Endocrinol 185(2):253–263
Baisden B, Sonne S, Joshi RM, Ganapathy V, Shekhawat PS (2007) Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta. Placenta 28(10):1082–1090
Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341(8850):938–941
Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR (1993) Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341(8841):339–341
Binetruy B, Heasley L, Bost F, Caron L, Aouadi M (2007) Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinases. Stem Cells 25(5):1090–1095
Bissonauth V, Roy S, Gravel M, Guillemette S, Charron J (2006) Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis. Development 133(17):3429–3440
Blair E, Stanley F (1990) Intrauterine growth and spastic cerebral palsy. I. Association with birth weight for gestational age. Am J Obstet Gynecol 162(1):229–237
Bloom SL, Sheffield JS, McIntire DD, Leveno KJ (2001) Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 97(4):485–490
Braun T, Li S, Moss TJ, Newnham JP, Challis JR, Gluckman PD, Sloboda DM (2007) Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep. J Endocrinol 194(2):337–347
Brodsky D, Christou H (2004) Current concepts in intrauterine growth restriction. J Intensive Care Med 19(6):307–319
Daoud G, Amyot M, Rassart E, Masse A, Simoneau L, Lafond J (2005) ERK1/2 and p38 regulate trophoblasts differentiation in human term placenta. J Physiol 566(Pt 2):409–423
Dickinson RJ, Keyse SM (2006) Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 119(Pt 22):4607–4615
Forbes K, Westwood M (2008) The IGF axis and placental function a mini review. Horm Res 69(3):129–137
Franke TF, Kaplan DR, Cantley LC (1997) PI3 K: downstream AKTion blocks apoptosis. Cell 88(4):435–437
Garcia Z, Kumar A, Marques M, Cortes I, Carrera AC (2006) Phosphoinositide 3-kinase controls early and late events in mammalian cell division. EMBO J 25(4):655–661
Georgiades P, Ferguson-Smith AC, Burton GJ (2002) Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23(1):3–19
Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S, Larouche L, Rousseau S, Huot J, Landry J, Jeannotte L, Charron J (1999) Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol 9(7):369–372
Gluckman PD (2001) Editorial: nutrition, glucocorticoids, birth size, and adult disease. Endocrinology 142(5):1689–1691
Hahn D, Blaschitz A, Korgun ET, Lang I, Desoye G, Skofitsch G, Dohr G (2001) From maternal glucose to fetal glycogen: expression of key regulators in the human placenta. Mol Hum Reprod 7(12):1173–1178
Hajduch E, Litherland GJ, Hundal HS (2001) Protein kinase B (PKB/Akt)–a key regulator of glucose transport? FEBS Lett 492(3):199–203
Hales CN, Desai M, Ozanne SE, Crowther NJ (1996) Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. Biochem Soc Trans 24(2):341–350
Hatano N, Mori Y, Oh-hora M, Kosugi A, Fujikawa T, Nakai N, Niwa H, Miyazaki J, Hamaoka T, Ogata M (2003) Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8(11):847–856
Hewitt DP, Mark PJ, Waddell BJ (2006) Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology 147(12):5568–5574
Jiang BH, Liu LZ (2008) PI3 K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784(1):150–158
Johnstone ED, Mackova M, Das S, Payne SG, Lowen B, Sibley CP, Chan G, Guilbert LJ (2005) Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts. Placenta 26(7):548–555
Kim D, Chung J (2002) Akt: versatile mediator of cell survival and beyond. J Biochem Mol Biol 35(1):106–115
Kolch W (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351(Pt 2):289–305
Korgun ET, Dohr G, Desoye G, Demir R, Kayisli UA, Hahn T (2003) Expression of insulin, insulin-like growth factor I and glucocorticoid receptor in rat uterus and embryo during decidualization, implantation and organogenesis. Reproduction 125(1):75–84
Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, Vimercati A, Scioscia M, Selvaggi L, Giorgino R, Greco P, Giorgino F (2005) Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 146(3):1498–1505
Levitt NS, Lindsay RS, Holmes MC, Seckl JR (1996) Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64(6):412–418
Liang J, Slingerland JM (2003) Multiple roles of the PI3 K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2(4):339–345
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Luttrell LM (2003) ‘Location, location, location’: activation and targeting of MAP kinases by G protein-coupled receptors. J Mol Endocrinol 30(2):117–126
Martins JP, Monteiro JC, Paixao AD (2003) Renal function in adult rats subjected to prenatal dexamethasone. Clin Exp Pharmacol Physiol 30(1–2):32–37
McDonald TJ, Franko KL, Brown JM, Jenkins SL, Nathanielsz PW, Nijland MJ (2003) Betamethasone in the last week of pregnancy causes fetal growth retardation but not adult hypertension in rats. J Soc Gynecol Investig 10(8):469–473
Meloche S, Vella FD, Voisin L, Ang SL, Saba-El-Leil M (2004) Erk2 signaling and early embryo stem cell self-renewal. Cell Cycle 3(3):241–243
Mikula M, Schreiber M, Husak Z, Kucerova L, Ruth J, Wieser R, Zatloukal K, Beug H, Wagner EF, Baccarini M (2001) Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 20(8):1952–1962
Mitsiades CS, Mitsiades N, Koutsilieris M (2004) The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 4(3):235–256
Nadeau V, Guillemette S, Belanger LF, Jacob O, Roy S, Charron J (2009) Map2k1 and Map2k2 genes contribute to the normal development of syncytiotrophoblasts during placentation. Development 136(8):1363–1374
Navarrete Santos A, Tonack S, Kirstein M, Pantaleon M, Kaye P, Fischer B (2004) Insulin acts via mitogen-activated protein kinase phosphorylation in rabbit blastocysts. Reproduction 128(5):517–526
Neri LM, Borgatti P, Capitani S, Martelli AM (2002) The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta 1584(2–3):73–80
Pawson T (2002) Regulation and targets of receptor tyrosine kinases. Eur J Cancer 38(Suppl 5):S3–10
Pollheimer J, Knofler M (2005) Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. Placenta 26(Suppl 1):S21–30
Prast J, Saleh L, Husslein H, Sonderegger S, Helmer H, Knofler M (2008) Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling. Endocrinology 149(3):979–987
Qian X, Esteban L, Vass WC, Upadhyaya C, Papageorge AG, Yienger K, Ward JM, Lowy DR, Santos E (2000) The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. EMBO J 19(4):642–654
Riley JK, Carayannopoulos MO, Wyman AH, Chi M, Ratajczak CK, Moley KH (2005) The PI3 K/Akt pathway is present and functional in the preimplantation mouse embryo. Dev Biol 284(2):377–386
Romeis B (1989) Mikroskopische Technik, 17th edn. Urban and Schwarzenberg, Munich
Rossant J, Cross JC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2(7):538–548
Saba-El-Leil MK, Vella FD, Vernay B, Voisin L, Chen L, Labrecque N, Ang SL, Meloche S (2003) An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development. EMBO Rep 4(10):964–968
Seckl JR (1994) Glucocorticoids and small babies. Q J Med 87(5):259–262
Sugden MC, Langdown ML, Munns MJ, Holness MJ (2001) Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring. Eur J Endocrinol 145(4):529–539
Unek G, Ozmen A, Kipmen-Korgun D, Korgun ET (2011) Immunolocalization of PCNA, Ki67, p27 and p57 in normal and dexamethasone-induced intrauterine growth restriction placental development in rat. Acta Histochem. doi:10.1016/j.acthis.2011.02.002
Waddell BJ, Hisheh S, Dharmarajan AM, Burton PJ (2000) Apoptosis in rat placenta is zone-dependent and stimulated by glucocorticoids. Biol Reprod 63(6):1913–1917
Watson ED, Cross JC (2005) Development of structures and transport functions in the mouse placenta. Physiology (Bethesda) 20:180–193
Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings BA (2003) Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278(34):32124–32131
Acknowledgments
This work was supported by the Research Foundation of Akdeniz University, Antalya, Turkey (project number: 2007.02.0122.013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ozmen, A., Unek, G., Kipmen-Korgun, D. et al. The expression of Akt and ERK1/2 proteins decreased in dexamethasone-induced intrauterine growth restricted rat placental development. J Mol Hist 42, 237–249 (2011). https://doi.org/10.1007/s10735-011-9328-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-011-9328-4